InvestorsHub Logo
Followers 18
Posts 758
Boards Moderated 0
Alias Born 10/23/2008

Re: None

Monday, 01/04/2021 3:02:22 AM

Monday, January 04, 2021 3:02:22 AM

Post# of 219
phase 2 clinical trials. looking to enter on extended pullback from recent high of $1.92 on 12/15/20

https://www.cybin.com/

Cybin is a life sciences company advancing psychedelic pharmaceutical treatments for various psychiatric and neurological conditions. Cybin is developing technologies and delivery systems, aiming to improve bioavailability, to potentially achieve the desired medicinal effects of psychedelics at low dosage levels. The new delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYBN News